Showing results (31-40 of 54) with videos related to
Sort By:
Pageof 6
Neuroscience Letters|May 24, 2008
Reduced numbers of dopamine neurons in the substantia nigra pars compacta and ventral tegmental area of rats fed an n-3 polyunsaturated fatty acid-deficient diet: a stereological studyS Omar Ahmad, Ji-Hyuk Park, Jeffery D Radel, et al.Lipids|August 29, 2006
Differential effects of modulation of docosahexaenoic acid content during development in specific regions of rat brainBeth Levant, Marlies K Ozias, Karra A Jones, et al.Lipids|July 30, 2013
Streptozotocin-induced diabetes partially attenuates the effects of a high-fat diet on liver and brain fatty acid composition in miceBeth Levant, Marlies K Ozias, Brianne L Guilford, et al.Electroanalysis|June 30, 2018
Regional differences in dopamine release in the R6/2 mouse caudate putamenSam V Kaplan, Ryan A Limbocker, Beth Levant, et al.Bioorganic & Medicinal Chemistry Letters|October 27, 2004
Design, synthesis, and evaluation of hexahydrobenz[f]isoquinolines as a novel class of dopamine 3 receptor ligandsXihan Wu, Jianyong Chen, Min Ji, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 28, 2020
The adverse effects of pramipexole on probability discounting are not reversed by acute D<sub>2</sub> or D<sub>3</sub> receptor antagonismMarco Orrù, Hunter J Strathman, Gabriele Floris, et al.Neuroscience and Biobehavioral Reviews|June 19, 2016
Lipids in psychiatric disorders and preventive medicineMiriam Schneider, Beth Levant, Martin Reichel, et al.Journal of Medicinal Chemistry|October 3, 2003
Molecular modeling of the three-dimensional structure of dopamine 3 (D3) subtype receptor: discovery of novel and potent D3 ligands through a hybrid pharmacophore- and structure-based database searching approachJudith Varady, Xihan Wu, Xueliang Fang, et al.ACS Medicinal Chemistry Letters|November 30, 2011
CJ-1639: A Potent and Highly Selective Dopamine D3 Receptor Full AgonistJianyong Chen, Gregory T Collins, Beth Levant, et al.Bioorganic & Medicinal Chemistry Letters|March 5, 2005
Design, synthesis and structure-activity relationship studies of hexahydropyrazinoquinolines as a novel class of potent and selective dopamine receptor 3 (D3) ligandsMin Ji, Jianyong Chen, Ke Ding, et al.Pageof 6